A detailed history of Great Lakes Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 1,473,117 shares of MRK stock, worth $188 Million. This represents 1.73% of its overall portfolio holdings.

Number of Shares
1,473,117
Previous 1,030,880 42.9%
Holding current value
$188 Million
Previous $112 Million 72.95%
% of portfolio
1.73%
Previous 1.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $50.1 Million - $58.4 Million
442,237 Added 42.9%
1,473,117 $194 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $3.18 Million - $3.47 Million
-31,788 Reduced 2.99%
1,030,880 $112 Million
Q3 2023

Nov 07, 2023

BUY
$102.95 - $114.33 $3.82 Million - $4.25 Million
37,135 Added 3.62%
1,062,668 $109 Million
Q2 2023

Aug 10, 2023

SELL
$108.61 - $118.38 $14.9 Million - $16.2 Million
-136,927 Reduced 11.78%
1,025,533 $118 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $56.5 Million - $63 Million
548,448 Added 89.32%
1,162,460 $124 Million
Q4 2022

Feb 09, 2023

SELL
$87.44 - $112.11 $11.3 Million - $14.5 Million
-129,236 Reduced 17.39%
614,012 $68.1 Million
Q3 2022

Nov 09, 2022

SELL
$84.53 - $94.96 $2.1 Million - $2.36 Million
-24,901 Reduced 3.24%
743,248 $64 Million
Q2 2022

Aug 09, 2022

BUY
$83.49 - $94.64 $2.34 Million - $2.65 Million
28,037 Added 3.79%
768,149 $70 Million
Q1 2022

May 06, 2022

SELL
$73.51 - $82.4 $1.43 Million - $1.61 Million
-19,508 Reduced 2.57%
740,112 $60.7 Million
Q4 2021

Feb 09, 2022

SELL
$72.28 - $90.54 $1.8 Million - $2.26 Million
-24,938 Reduced 3.18%
759,620 $58.2 Million
Q3 2021

Nov 09, 2021

SELL
$71.68 - $78.83 $156,979 - $172,637
-2,190 Reduced 0.28%
784,558 $58.9 Million
Q2 2021

Aug 11, 2021

BUY
$70.31 - $77.77 $4.02 Million - $4.45 Million
57,244 Added 7.85%
786,748 $61.2 Million
Q1 2021

May 03, 2021

BUY
$68.86 - $81.11 $10.1 Million - $11.9 Million
147,017 Added 25.24%
729,504 $56.2 Million
Q4 2020

Feb 09, 2021

BUY
$71.77 - $79.65 $2.12 Million - $2.35 Million
29,541 Added 5.34%
582,487 $47.6 Million
Q3 2020

Nov 04, 2020

BUY
$73.18 - $82.95 $372,998 - $422,796
5,097 Added 0.93%
552,946 $45.9 Million
Q2 2020

Aug 07, 2020

SELL
$70.42 - $80.13 $4.82 Million - $5.49 Million
-68,479 Reduced 11.11%
547,849 $42.4 Million
Q1 2020

May 08, 2020

SELL
$63.36 - $87.82 $895,466 - $1.24 Million
-14,133 Reduced 2.24%
616,328 $47.4 Million
Q4 2019

Feb 07, 2020

SELL
$77.58 - $87.54 $10.3 Million - $11.6 Million
-133,080 Reduced 17.43%
630,461 $57.3 Million
Q3 2019

Nov 06, 2019

SELL
$76.08 - $82.93 $2.33 Million - $2.54 Million
-30,665 Reduced 3.86%
763,541 $64.3 Million
Q2 2019

Aug 05, 2019

BUY
$69.84 - $81.59 $13.3 Million - $15.5 Million
190,326 Added 31.52%
794,206 $66.6 Million
Q1 2019

May 07, 2019

SELL
$69.58 - $79.36 $20.7 Million - $23.6 Million
-297,162 Reduced 32.98%
603,880 $50.2 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $19.6 Million - $22.7 Million
-300,222 Reduced 24.99%
901,042 $68.8 Million
Q3 2018

Nov 30, 2018

BUY
$57.69 - $67.84 $68.6 Million - $80.7 Million
1,189,604 Added 10202.44%
1,201,264 $85.2 Million
Q3 2018

Nov 15, 2018

SELL
$57.69 - $67.84 $65.6 Million - $77.1 Million
-1,136,456 Reduced 98.98%
11,660 $827,000
Q2 2018

Aug 13, 2018

SELL
$50.83 - $59.72 $11.5 Million - $13.5 Million
-226,136 Reduced 16.46%
1,148,116 $69.7 Million
Q1 2018

May 07, 2018

BUY
$50.96 - $59.23 $10.2 Million - $11.8 Million
199,999 Added 17.03%
1,374,252 $66.5 Million
Q4 2017

Feb 08, 2018

BUY
$51.62 - $61.64 $9.79 Million - $11.7 Million
189,644 Added 19.26%
1,174,253 $66.1 Million
Q3 2017

Nov 13, 2017

BUY
$58.67 - $63.13 $57.8 Million - $62.2 Million
984,609
984,609 $63 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $324B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.